SCHEMBL21187222

SCHEMBL21187222

C=CCCCN(C)[C@H]1CC[C@@H](N(C)C(C)C)CC1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EBP Q15125 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13013674 0.88 EBP (0.37) EBP
SCHEMBL23776737 0.78 EBP (0.36) EBP
SCHEMBL19943667 0.76 EBP (0.34) EBP
SCHEMBL18685384 0.75 KDM4E (0.36) EBP
SCHEMBL21187224 0.73 EBP (0.31) EBP
SCHEMBL23197986 0.72 TSHR (0.33) EBP
SCHEMBL13397343 0.71
SCHEMBL18458215 0.71 ADH1B (0.32)
SCHEMBL26404423 0.70 PIK3CD (0.36)
SCHEMBL22856311 0.69 PIK3CD (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019144098-A1 COMPOSITIONS AND METHODS OF TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2019-07-25 WO disclosed